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Abstract 
 
Background: Eremomastax speciosa (Hochst.) Cufod is a perennial herb found in Africa along the rainforest zone and 
occurs as weed. It is cultivated in Cameroon and Akwa-Ibom in Nigeria due to its medicinal values. This study 
investigated the antioxidant, anti-inflammatory and antinociceptive properties of hydromethanol extract of 
Eremomastax speciosa (Hochst.) Cufod leaf in rat model. 
Materials and Methods: The plant material was extracted using cold maceration method in 80% hydromethanol. The 
acute oral toxicity test was performed using Up and Down method with limit dose of 2000 mg/kg. The in vitro 
antioxidant property was evaluated with 2,2-diphenyl-1-picrylhydrazyl and ferric reducing antioxidant power 
photometric assays. The anti-inflammatory potential was investigated in egg-albumin and carrageenan induced paw 
edema models while the antinociceptive activity was determined using acetic acid induced writhing reflex and tail 
immersion tests at the doses of 50, 100 and 200 mg/kg. The negative control group (group A) received distilled water 
(vehicle) at 5 ml/kg while acetyl salicylic acid (200 mg/kg) was used as the reference drug for the anti-inflammatory 
models and acetic acid induced writhing reflex model while pentazocine (5 mg/kg) was used as the reference drug for 
tail immersion test. 
Results: The LD50 of the extract was greater than 2000 mg/kg. The extract (25 to 400 µg/ml) demonstrated potent 
antioxidant activities in both the 2,2-diphenyl-1-picrylhydrazyl and ferric reducing antioxidant power assays. The E. 
speciosa extract caused significant (P < 0.05) anti-inflammatory and antinociceptive activities in the extract treated 
groups when compared to rats that received distilled water. The optimal activities of the extract were produced at the 
dose of 100 mg/kg.  
Conclusion: The study supports the folkloric use of Eremomastax speciosa leaf in the management of pain and 
inflammatory conditions in traditional medicine. 
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Introduction 
 
Eremomastax speciosa (Hochst.) Cufod commonly known as “edem iduodut” or “ndadad edem” by Ibibio 
people and “African blood tonic” in Cameroon belong to the family Acanthaceae (Iba et al., 2015). It is a perennial 
herb found in Africa along the rainforest zone and occurs as weed. It is cultivated in Cameroon and Akwa-Ibom in 
Nigeria due to its medicinal values (Oben et al., 2006). It is a polymorphous herb that grows up to 2 m high with 
remarkable quadrangular stem (Amang et al., 2014). The leaf (decoction or infusion or maceration) is used by the 
natives in the treatment of dysentery, anaemia, menstrual pain, fracture, hemorrhoids and urinary tract infection (Iba et 
al., 2015; Oben et al., 2006; Kuete et al., 2013). The aerial part of the plant has been reported in scientific literature to 
possess antianaemic, antiulcer, antisecretory, antimicrobial, antifungal and antidiarrheal activities (Amang et al., 2014; 
Iba et al., 2015; Oben et al., 2006; Okokon et al., 2007; Mouokeu et al., 2015; Tan et al., 1996). There was dearth of 
information on the anti-inflammatory and antinociceptive activities of E. speciosa, despite its use for this purpose in  
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traditional medicine of various cultures. The main aim of the study was to investigate the antioxidant, anti-
inflammatory and antinociceptive activities of methanol extract of E. speciosa (Hochst.) Cufod leaf. 
 
Materials and Methods   
Harvest and identification plant sample 
 
The leaves of E. speciosa (Hochst.) Cufod were harvested from uncultivated farmlands in June 2015 from 
Ikot-Ekwere Itam in Itu, Akwa-Ibom State Nigeria and identified by Mr. Okon Etefia. A voucher sample label 
MOUAU/VPP/2015/15 was deposited in the departmental herbarium for reference purposes.  
 
 
Figure 1: Photograph of Eremomastax speciosa (Hochst.) Cufod 
 
Preparation of E. speciosa extract  
 
The leaves of E. speciosa were air dried under shed and ground into coarse powder with manual milling 
machine (Corona, China). Two hundred grams (200 g) of the coarse powder of E. speciosa was soaked in 80% 
hydromethanol (Sigma Aldrich, USA) for 48 h (2 days) at room temperature with intermittent agitation (3 h interval) in 
a Winchester bottle and filtered with Whatman No. 1 filter papers. The filtrate was concentrated at 40 oC in hot air oven 
and the extract was stored in a refrigerator at 4 oC as E. speciosa extract (ESE) (Onoja et al., 2016). The percentage 
yield was calculated as follow;  
% yield (w/w) =  
 
Antioxidant study 
2, 2-Diphenyl-1-picrylhydrazyl (DPPH) scavenging Assay 
  
The DPPH (Sigma Aldrich, USA) radical scavenging activity of ESE was determined as described by Ezeja et 
al. (2015) at 25, 50, 100, 200 and 400 µg/ml concentrations in triplicate and ascorbic acid was used as standard. 
 
Ferric reducing antioxidant power (FRAP) 
 
The FRAP of ESE was evaluated as described in Onoja et al. (2016). The FRAP of ESE at 25, 50, 100, 200 
and 400 µg/ml concentrations was determined in triplicate.  
 
Experimental animals 
 
Total of 126 Wistar albino rats of either sexes weighing 90-105 g were employed in the study. The rats were 
kept in stainless steel cages at ambient temperature and natural light/darkness cycles. The rats were given clean tap 
water and fed ad libitum with commercial feed (Vital feed® Nigeria). The rats were managed in accordance with the 
recommendations of the guide for the care and use of laboratory animals (Ward and Elsea, 1997) and the experimental 
protocol was approved by the institution’s ethical committee.  
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Oral acute toxicity test 
 
The Up and Down method of oral acute toxicity test was used to determine the LD50 (OECD, 2008). Three rats 
received 2000 mg/kg of ESE while three other rats were given same volume of distilled water, orally by gastric gavage. 
The rats were monitored for 48 h for signs of toxicity and mortality. 
 
Anti-inflammatory study 
Carrageenan – induced paw edema 
 
The modified carrageenan–induced paw edema model described by Ghante et al. (2014) was employed in the 
conduct of this experimental protocol. Briefly, 30 albino rats were randomly assigned to 5 groups (A-E) (n = 6). The 
rats in group A received 5 ml/kg of distilled water (DW) (negative (-ve) control), group B rats received 200 mg/kg of 
acetylsalicylic acid (ASA) (positive (+ve) control) while rats in groups C, D and E received 50, 100 and 200 mg/kg of 
ESE, respectively. Sixty minutes post administration of ASA and ESE, 0.1 ml of carrageenan (Sigma Aldrich, USA) 
(0.5 % in normal saline) was injected into the sub-plantar area of the right hind paw. The paw volumes of the rats were 
estimated through displacement of water and measured with electronic balance of 0.01 g accuracy. The left paw 
volumes served as control (Vo). The volume (Vt) of the right hind paw was measured at 1, 2 and 3 h post carrageenan 
administration. The change in volume due to carrageenan-induced paw swelling was calculated as (Vt – Vo) while the 
percent inhibition was calculated using the formula below:  Percent inhibition =   
Where Y is the change in paw volume (Vt – Vo) of distilled water treated group and Z is the change in paw volume (Vt 
– Vo) of each test group. 
 
Egg-albumin-induced paw edema 
 
The method of Ghule et al. (2006) was adopted for this experiment. Thirty albino rats fasted overnight (16 h) 
were randomly assigned into 5 groups (A-E) (n = 6). Group A rats received 5 ml/kg of DW (-ve control), rats in group 
B were treated with 200 mg/kg of ASA (+ve control) and group C, D and E were treated with 50, 100 and 200 mg/kg of 
ESE, respectively. Thirty minutes after treatment; paw edema was induced by injecting 0.05 ml of raw egg-albumin 
into the sub-plantar area of the hind right paw. The left paw volumes served as control. The right paw volume was 
determined at 1, 2 and 3 h post treatment. Measurement and percent inhibition were as stated above. 
 
Antinociceptive study 
Acetic acid-induced abdominal writhing reflex in rats 
 
 The Effects of ESE on acetic acid induced abdominal writhing reflex was conducted according to the method 
of Zakaria et al. (2001). Briefly, 30 rats were assigned to five groups (A-E) (n = 6). Group A rats served as -ve control 
and received DW (5 ml/kg) while rats in group B served as +ve control and received ASA (200 mg/kg). Groups C-E 
rats received 100, 200 and 400 mg/kg extract, respectively. The treatments were administered orally. Forty five (45) 
min post treatment, the rats received 10 ml/kg of 0.7% acetic acid intraperitoneally (i.p). The abdominal stretches 
produced in each rat were counted for 30 min. Percent activity was calculated using the formula below:   
Where X is the mean writhing reflex of distilled water treated group and Y is the mean writhing reflex of each test 
groups. 
 
Tail immersion test  
 
 The experiment was conducted as described by Alam et al. (2009). Thirty rats were randomly assigned to 5 
groups (A-E) (n = 6). Group A received DW 5 ml/kg orally (-ve control), Group B received pentazocine 5 mg/kg (i.p) 
(-ve control), while Groups C-E received extract 100, 200 and 400 mg/kg orally, respectively. One hour treatment, 
about 3 cm of the tail of each rat was dipped into a water bath maintained at a temperature of 55 ± 1°C. The pain 
reaction time (PRT) each rat was recorded. Percent antinociception was calculated using the formula below: percent 
antinociception =  
Where To is the mean PRT of distilled water treated group and Tt is the mean PRT of each test groups. 
 
Data analysis 
 
Data were presented as mean ± standard error of mean (SEM) and analyzed with statistical package of social 
science (SPSS) version 20 using one way analysis of variance (ANOVA). Least Significant Difference (LSD) was used 
to separate mean difference and significance was accepted at the level of p < 0.05. 
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Results 
In vitro antioxidant activities of ESE 
The DPPH radical scavenging activity of ESE 
 
The ESE caused a significant (p < 0.05) concentration dependent increase in the antioxidant activity. The 
optimal effect was produced at 400 µg/ml concentration. The inhibition concentration 50% (IC50) of the extract is 
approximately 200 µg/ml concentration. The antioxidant activities of ESE was significantly (p<0.05) lower than that of 
ascorbic acid (Figure 2). 
 
 
 
Figure 2: The 2,2-diphenyl-1-picrylhydrazyl radical scavenging activities of ESE 
Legend: ESE = Eremomastax speciosa extract; SEM = standard error of mean. 
 
FRAP assay 
   
The ESE caused concentration dependent increase in antioxidant power. The antioxidant power of the extract 
is significantly (p<0.05) lower than ascorbic acid (Figure 3). 
 
 
 
Figure 3: Ferric reducing antioxidant power of ESE. 
Legend: ESE = Eremomastax speciosa extract; FRAP = ferric reducing antioxidant power; SEM = standard error of 
mean. 
 
Oral acute toxicity test 
 
Eremomastax speciosa (ESE) did not cause observable clinical signs of toxicity and mortality in treated rats at 
dose of 2000 mg/kg. The LD50 of ESE is greater than 2000 mg/kg. 
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Carrageenan induced paw edema  
 
The ASA and ESE treatment caused reduced paw volume in the treated rats when compared to DW treated 
group. The extract (100 mg/kg) significantly (P < 0.05) reduced the paw volumes of the treated rats at 1, 2 and 3 h post 
treatment when compared DW treated rats. (Table 1). 
 
Table 1: Effect of ESE on carrageenan induced paw edema 
 
Treatment 
Mean increase in paw volume (ml) ± SEM (% inhibition) 
1 h 2 h 3 h 
    DW 5 mg/kg 0.50 ± 0.03(-) 0.66 ± 0.03(-) 0.68 ± 0.05(-) 
ASA 200 mg/kg 0.47 ± 0.06(6) 0.61 ± 0.05(8) 0.65 ± 0.04(4) 
ESE 50 mg/kg 0.49 ± 0.07(2) 0.65 ± 0.04(3) 0.63 ± 0.04(7) 
ESE 100 mg/kg 0.38 ± 0.05*(24) 0.49 ± 0.04*(26)  0.58 ± 0.03*(15) 
ESE 200 mg/kg 0.46 ± 0.04(8) 0.65 ± 0.04(2) 0.70 ± 0.04(-3) 
*p<0.05 when compared to DW treated group. SEM = standard error of mean, DW = water distilled, ESE = 
Eremomastax speciosa extract; ASA = acetyl salicylic acid; h = hour; % = percentage; ml = mililitre. 
 
Egg albumin-induced paw edema 
 
The ESE significantly (p < 0.05) decreased the paw volume of the treated rats in a non dose-dependent manner 
when compared to the DW treated rats. At 3 h post treatment, the paw volume of the negative control was 0.91 ± 0.04 
ml while the paw volumes of ASA and ESE (50, 100 and 200 mg/kg) treated rat groups were 0.57 ± 0.04, 0.57 ± 0.03, 
0.59 ± 0.05 and 0.61 ± 0.06, respectively (Table 2). 
 
Acetic acid-induced writhing reflex  
 
Acetyl salicylic acid and ESE (100 and 200 mg/kg) caused significant (P < 0.05) reduction in writhing reflex 
in the treated rats when compared to DW treated rats (Table 3). 
 
Table 2: Effect of ESE on egg albumin-induced paw edema 
 
Group (n = 6) 
Mean increase in paw volume (ml) ± SEM (% inhibition) 
1 h 2 h 3 h 
DW 5 mg/kg 1.16 ± 0.08 (-) 0.94 ± 0.05(-) 0.91 ± 0.04(-) 
ASA 200 mg/kg 0.87 ± 0.03*(25)  0.64 ± 0.01*(32) 0.57 ± 0.04*(37) 
ESE 50 mg/kg 0.88 ± 0.05*(24) 0.68 ± 0.07*(28) 0.57 ± 0.03*(37) 
ESE 100 mg/kg 0.95 ± 0.05*(18) 0.80 ± 0.04*(15) 0.59 ± 0.05*(35) 
ESE 200 mg/kg 1.02 ± 0.08 (12) 0.78 ± 0.08*(17) 0.61 ± 0.06*(33) 
*p<0.05 when compared to DW treated group. SEM = standard error of mean, DW = water distilled, ESE = 
Eremomastax speciosa extract; ASA = acetyl salicylic acid; h = hour; % = percentage; ml = mililitre. 
 
Table 3: Effect of ESE on acetic acid-induced writhing reflex  
Group (n = 6) Mean writhing reflex ± SEM % inhibition 
DW 5 mg/kg 32.20 ± 0.73 - 
ASA 200 mg/kg 22.30 ± 0.91*** 30.75 
ESE 50 mg/kg 30.00 ± 0.71 6.83 
ESE 100 mg/kg 23.20 ± 1.07*** 27.95 
ESE 200 mg/kg 27.20 ± 1.59*** 15.53 
*P<0.05; **P<0.01; ***P<0.001 when compared to DW treated group. SEM = standard error of mean, DW = water 
distilled, ESE = Eremomastax speciosa extract; ASA = acetyl salicylic acid; % = percentage. 
 
Tail immersion test  
Pentazocine (5 mg/kg) and ESE (50, 100 and 200 mg/kg) caused prolonged (P < 0.05) PRT in treated rats when 
compared to the DW treated rats. Pentazocine and ESE (100 mg/kg) caused significant (P < 0.05) increase in PRT (3.32 
± 0.42 and 3.08 ± 0.33 respectively) of the treated groups when compared to DW treated group (2.29 ± 0.17). There 
was no significant (p < 0.05) difference between pentazocine and ESE, 100 mg/kg treated groups (Table 4). 
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Table 4: Effect of ESE in tail immersion test  
Group (n = 6) PRT (sec) ± SEM % increase in PRT 
DW 10 mg/kg 2.29 ± 0.17 - 
Pentazocine 5 mg/kg 3.32 ± 0.42* 44.98 
ESE 50 mg/kg 2.58 ± 0.30 12.66 
ESE 100 mg/kg 3.08 ± 0.33* 34.50 
ESE 200 mg/kg 2.50 ± 0.28 9.17 
*p<0.05 when compared to DW treated group. SEM = standard error of mean; DW = water distilled; ESE = 
Eremomastax speciosa extract; ASA = acetyl salicylic acid; PRT = Pain reaction time; h = hour; % = percentage; Sec = 
second. 
 
Discussion 
 
Oral acute toxicity of the extract of Eremomastax speciosa (ESE) did not cause any observable clinical signs 
of toxicity and mortality in treated rats at dose of 2000 mg/kg. This indicates that the oral LD50 of the ESE was greater 
than 2000 mg/kg.   
The extract demonstrated good anti-inflammatory, antinociceptive and antioxidant properties which may be 
attributed to the phytoconstituents. Ndam et al. (2014) reported that E. speciosa contain flavonoids, saponins and 
terpenes. The anti-inflammatory, antioxidant and antinociceptive properties of these phytoconstituents have been 
documented (Aladedunye et al., 2008; Otimenyin et al., 2008). 
The mechanism of the anti-inflammatory and antinociceptive effect of E. speciosa was not established, but 
could be through inhibition of cyclooxygenase activity. Cyclooxygenase catalyze the biosynthesis of prostaglandins 
(potent inflammatory mediator) from arachidonic acid (Alam et al., 2009). Most non-steroidal anti-inflammatory drugs 
act via the inhibition of cyclooxygenase (Rang et al., 2007; Balakumar et al., 2010). 
Egg-albumin, carrageenan and acetic acid induces inflammation and pain sensation through stimulation of 
inflammatory mediators (cytokine, histamine, prostaglandins, polymorphonuclear leucocytes and thromboxane) in the 
tissue and increased vascular permeability (Marsik et al., 2005; Silva et al., 2014). The extract might have acted 
through the inhibition of synthesis and migration of inflammatory mediator to the site of inflammation. Hassan et al. 
(2016) reported the anti-inflammatory properties of Cajanus cajan extract and proposed inhibition of inflammatory 
mediators migration as its mechanism of action.  
Also, the anti-inflammatory effects of E. speciosa may be linked to antioxidant activity. Silva et al. (2014) 
associated the anti-inflammatory effects of phytol, a diterpene to its antioxidant property. Inflammatory reaction is 
usually associated with reactive oxygen species which are mopped up by antioxidant. Also, antioxidant effects of E. 
speciosa will ameliorate oxidative stress which accompanies inflammatory conditions (Casado et al., 2010). 
The extract prolonged the pain reaction time (PRT) of the treated rats which suggests that it may be a centrally 
acting analgesic agent.  The increase in PRT may be due to elevation of pain threshold in the hypothalamus (Singh et 
al., 2016). The decrease in writhing reflex in the extract treated group suggests that E. speciosa has peripheral analgesic 
effects (Silva et al., 2003). 
The anti-inflammatory and antinociceptive activities of E. speciosa leaf are comparable to the effects produced 
by Ormosia coccinea and Phyllanthus maderaspatensis (Adnan et al., 2014; Wagle et al., 2016). The little difference in 
activities may be linked to variation in phytochemical constituents which depend on the stage of vegetative growth, part 
of the plant collected, soil type and other climatic factors (Sofowora, 2008). 
In conclusion, the methanol extract of E. speciosa demonstrated good anti-inflammatory, antinociceptive and 
antioxidant properties. The results support the folkloric use of Eremomastax speciosa leaf in the management of pain 
and inflammatory conditions. The plant may provide source of novel anti-inflammatory and antinociceptive drug(s). 
Further studies aimed at isolation and characterizations of active principles are ongoing in our laboratory. 
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